? VDDRC PILOT AND FEASIBILITY PROGRAM The Pilot and Feasibility (P/F) Program is a vital, essential component of the Vanderbilt DDRC (VDDRC). It directly supports the overall goals of the VDDRC, which are to: 1) promote digestive diseases research in an integrative, collaborative, and multidisciplinary manner; 2) attract new investigators to the study of these disorders; 3) enhance the innovative research capabilities of members; and 4) promote the career development of junior investigators. Through the P/F Program, we have a strong track record of recruiting highly talented young investigators and established investigators that are new to digestive disease research, as well as established GI investigators testing exciting new ideas. In the past 10 years, we have supported 58 P/F recipients, with 27 of these in the past 5 years. Our number of grants and the amount of support is greatly enhanced by a commitment of $100,000 per year from VUMC, plus additional funding available from the Vanderbilt Institute for Clinical and Translational Research (VICTR, Vanderbilt CTSA). Over the past two grant award cycles (years 6-15), P/F recipients have garnered $47,707,648 in Direct Cost funding subsequent to their P/F awards, yielding a 30? fold return on investment of the NIH funds used for P/F awards. We have demonstrated major benefits to the career development of PIs that were supported as Type N (New Investigators) in the P/F program, including development of faculty as transformers of their research fields and growth into academic leadership positions. The P/F Program has been directed since 2010 by Keith T. Wilson, M.D., Thomas F. Frist Sr. Professor of Medicine, Cancer Biology, and Pathology, Microbiology and Immunology, and Associate Director of the VDDRC. The VDDRC provides an applicant-friendly environment in which annual P/F grant opportunities are widely circulated via the VDDRC website and email announcements, and potential candidates interact directly with the P/F Director to ensure that their projects meet the goals of the VDDRC, optimize use of VDDRC Cores, and meet NIH guidelines for rigor and reproducibility.
Our Specific Aims are: 1) To recruit talented New Investigators (Type N) without current or past independent NIH support to digestive disease research, in order to provide a foundation for career development and future independent funding; all successful Type N recipients benefit from enrollment in the VDDRC Academy of Investigators. 2) To recruit established investigators new to digestive disease research (Type EN), by supporting their studies of a digestive disease- related problem, with the goal of fostering collaborations and new directions that may lead to subsequent related publications, projects, and research grants in the field. 3) To support established investigators (Type E) in the digestive disease field in the pursuit of highly innovative, exciting new ideas, which is a significant departure from their previous work, and is likely to result in an important and fruitful new line of investigation. The overall goal is enhanced digestive disease-related research with exciting and transformative new ideas that can be catalyzed by P/F support and extensive interaction with Center members and activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK058404-18
Application #
9710652
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
18
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Engevik, Amy C; Kaji, Izumi; Engevik, Melinda A et al. (2018) Loss of MYO5B Leads to Reductions in Na+ Absorption With Maintenance of CFTR-Dependent Cl- Secretion in Enterocytes. Gastroenterology 155:1883-1897.e10
Tafreshi, Mona; Guan, Jyeswei; Gorrell, Rebecca J et al. (2018) Helicobacter pylori Type IV Secretion System and Its Adhesin Subunit, CagL, Mediate Potent Inflammatory Responses in Primary Human Endothelial Cells. Front Cell Infect Microbiol 8:22
Rogers, Meredith C; Lamens, Kristina D; Shafagati, Nazly et al. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. J Immunol 201:1253-1266
Lowry, Mary Allyson; Vaezi, Michael F; Correa, Hernan et al. (2018) Mucosal Impedance Measurements Differentiate Pediatric Patients With Active Versus Inactive Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr 67:198-203
Pollins, Alonda C; Boyer, Richard B; Nussenbaum, Marlieke et al. (2018) Comparing Processed Nerve Allografts and Assessing Their Capacity to Retain and Release Nerve Growth Factor. Ann Plast Surg 81:198-202
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Scoville, Elizabeth A; Allaman, Margaret M; Brown, Caroline T et al. (2018) Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling. Metabolomics 14:
Ruiz, Rachel M; Sommer, Evan C; Tracy, Dustin et al. (2018) Novel patterns of physical activity in a large sample of preschool-aged children. BMC Public Health 18:242
Bolus, W Reid; Peterson, Kristin R; Hubler, Merla J et al. (2018) Elevating adipose eosinophils in obese mice to physiologically normal levels does not rescue metabolic impairments. Mol Metab 8:86-95
Loh, John T; Beckett, Amber C; Scholz, Matthew B et al. (2018) High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins. Infect Immun 86:

Showing the most recent 10 out of 1365 publications